Repligen Cp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGEN | AMGN | GILD | BIIB | CELG |
| Company | Repligen Cp | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 165.66 | 265.72 | 65.50 | 201.22 | 108.01 |
| High | 168.46 | 271.68 | 66.35 | 210.83 | 108.59 |
| Low | 165.04 | 265.72 | 64.63 | 199.78 | 107.27 |
| Last | 166.58 | 269.98 | 65.42 | 208.90 | 108.24 |
| Change | +0.92 | +0.60 | +0.15 | +6.44 | +0.11 |
| % Change | +0.56% | +0.22% | +0.23% | +3.18% | +0.10% |
| Volume | 341,269 | 2,436,908 | 12,348,617 | 1,879,342 | 191,230,496 |
| 20-Day Average Volume | 480,733 | 2,156,940 | 7,060,701 | 1,279,367 | 16,188,930 |
| Previous Close | 165.66 | 269.38 | 65.27 | 202.46 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 169.96 | 269.99 | 68.29 | 201.13 | 108.17 |
| 20-Day Raw Stochastic | 43.89% | 40.03% | 9.20% | 74.13% | 63.25% |
| 20-Day Relative Strength | 41.75% | 45.47% | 29.21% | 49.77% | 64.69% |
| Weighted Alpha | +0.58 | +9.45 | -23.49 | -31.63 | +46.30 |
| Today's Opinion | 40% Sell | 72% Sell | 100% Sell | 88% Sell | 100% Buy |
| Previous Opinion | 24% Sell | 72% Sell | 100% Sell | 88% Sell | 100% Buy |
| Last Month's Opinion | 40% Buy | 40% Buy | 88% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.01% since 04/19/24 | +0.39% since 04/19/24 | -2.01% since 04/19/24 | +7.47% since 04/19/24 | -1.97% since 11/13/19 |
| Low | 154.87 on 04/22/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 192.75 on 04/23/24 | 107.27 on 11/20/19 |
| High | 174.30 on 04/23/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 210.83 on 04/26/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | -9.39% since 03/26/24 | -4.18% since 03/26/24 | -9.65% since 03/26/24 | -1.47% since 03/26/24 | +5.14% since 10/18/19 |
| Low | 152.19 on 04/18/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 189.44 on 04/19/24 | 102.40 on 10/21/19 |
| High | 187.25 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 217.57 on 03/28/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | -13.87% since 01/26/24 | -13.40% since 01/26/24 | -17.73% since 01/26/24 | -14.67% since 01/26/24 | +13.63% since 08/20/19 |
| Low | 152.19 on 04/18/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 189.44 on 04/19/24 | 93.41 on 08/23/19 |
| High | 211.13 on 02/16/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 251.99 on 01/31/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | +35.98% since 10/26/23 | +0.10% since 10/26/23 | -16.66% since 10/26/23 | -13.35% since 10/26/23 | +14.14% since 05/20/19 |
| Low | 110.45 on 10/30/23 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 211.13 on 02/16/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,250,289 | 144,488,960 | 81,266,176 | 29,429,788 | 77,035,920 |
| Shares Outstanding, K | 55,839 | 536,376 | 1,245,077 | 145,361 | 711,714 |
| Annual Sales | 638,760,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | 41,580,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 155,740,000 | 8,196,000,000 | 7,114,000,000 | 2,386,300,000 | 4,520,000,000 |
| Last Quarter Net Income | -25,490,000 | 767,000,000 | 1,429,000,000 | 249,700,000 | 1,691,000,000 |
| 60-Month Beta | 1.02 | 0.58 | 0.19 | -0.02 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.33 on 02/21/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 3.67 on 04/24/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 05/01/24 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 97.03 | 14.64 | 9.98 | 13.47 | 10.99 |